Nanocarrier-based drug delivery systems hold impressive promise for biomedical
application because of their excellent water dispersibility, prolonged blood circulation time …

With the unprecedented progresses of biomedical nanotechnology during the past few
decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs …

The clinical application of chemotherapy is impeded by the unsatisfactory efficacy and
severe side effects. Chemodynamic therapy (CDT) has emerged as an efficient strategy for …

To promote the clinical theranostic performances of platinum‐based anticancer drugs,
imaging capability is urgently desired, and their chemotherapeutic efficacy needs to be …

Checkpoint blockade immunotherapy is promising for clinical treatment of various malignant
tumors. However, checkpoint blockade immunotherapy suffers from a low response rate due …

Carbon dots (CDs) are remarkable nanocarriers due to their promising optical and
biocompatible capabilities. However, their practical applicability in cancer therapeutics is …

Nanomedicine to overcome both systemic and tumor tissue barriers ideally should have a
transformable size and surface, maintaining a certain size and negative surface charge for …

Nucleolus tracking and nucleus-targeted photodynamic therapy are attracting increasing
attention due to the importance of nucleolus and the sensitivity of nucleus to various …

A light-activated hypoxia-responsive conjugated polymer-based nanocarrier is developed
for efficiently producing singlet oxygen (1O2) and inducing hypoxia to promote release of its …

Although cancer immunotherapy based on immune checkpoint inhibitors holds great
promise toward many types of cancers, several challenges still remain, associated with low …